Plasma levels of trefoil factors are increased in patients with advanced prostate cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. / Vestergaard, E.M.; Borregaard, Michael Krabbe; Poulsen, Steen Seier; Nexo, E.; Torring, N.
I: Clinical Cancer Research, Bind 12, Nr. 3 Pt 1, 2006, s. 807-812.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Plasma levels of trefoil factors are increased in patients with advanced prostate cancer
AU - Vestergaard, E.M.
AU - Borregaard, Michael Krabbe
AU - Poulsen, Steen Seier
AU - Nexo, E.
AU - Torring, N.
PY - 2006
Y1 - 2006
N2 - Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
AB - Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
KW - Aged
KW - Aged, 80 and over
KW - Enzyme-Linked Immunosorbent Assay
KW - Gene Expression Regulation, Neoplastic
KW - Humans
KW - Immunohistochemistry
KW - Male
KW - Middle Aged
KW - Peptides
KW - Prospective Studies
KW - Prostate-Specific Antigen
KW - Prostatic Neoplasms
KW - Sensitivity and Specificity
KW - Tumor Suppressor Proteins
U2 - 10.1158/1078-0432.CCR-05-1545
DO - 10.1158/1078-0432.CCR-05-1545
M3 - Journal article
C2 - 16467092
VL - 12
SP - 807
EP - 812
JO - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 3 Pt 1
ER -
ID: 1207944